EUVIMEDEUVIMED entdecken
Open Access

Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells

Adam Goldman iD, Emanuel Raschi iD, Joab Chapman, Bianca D Santomasso, Marcelo C Pasquini iD, Miguel-Angel Perales iD, Roni Shouval iD

Blood · 09.02.2023 · 141 (6) · 673-677

DOI: 10.1182/blood.2022017386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, erschienen am 09.02.2023. Verfasst von Adam Goldman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The Talpiot Sheba Medical Leadership Program, Chaim Sheba Medical Center, Ramat-Gan, Israel. Hauptthemen laut MEDLINE: Leukoencephalopathy, Progressive Multifocal, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using 2 global postmarketing surveillance databases, Goldman and colleagues report that progressive multifocal leukoencephalopathy (PML), a viral disease associated with profound immunosuppression, occurs in approximately 0.9 cases per 1000 recipients of CD19-directed CAR T-cell therapy. The risk of PML appears higher with CAR T-cell therapy than other cancer therapies, but its precise role cannot be distinguished from antecedent therapies that these patients receive.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukoencephalopathy, Progressive MultifocalReceptors, Chimeric AntigenHumansBrainMagnetic Resonance ImagingT-Lymphocytes

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Internal Medicine, The Talpiot Sheba Medical Leadership Program, Chaim Sheba Medical Center, Ramat-Gan, Israel.
  • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
  • Department of Neurology, The Chaim Sheba Medical Center, Ramat-Gan, Israel.
  • Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Adult Bone Marrow Transplantation Service and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.

ORCID-Profile: Adam Goldman, Emanuel Raschi, Marcelo C Pasquini, Miguel-Angel Perales, Roni Shouval

Förderung

  • NCI NIH HHS

Zitieren

APA

Goldman, A., Raschi, E., Chapman, J., Santomasso, B. D., Pasquini, M. C., Perales, M. A., & Shouval, R. (2023). Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells. Blood, 141(6), 673-677. https://doi.org/10.1182/blood.2022017386

Vancouver

Goldman A, Raschi E, Chapman J, Santomasso BD, Pasquini MC, Perales MA, et al. Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells. Blood. 2023;141(6):673-677. doi:10.1182/blood.2022017386

BibTeX
@article{Goldman2023,
  author = {Goldman, Adam and Raschi, Emanuel and Chapman, Joab and Santomasso, Bianca D and Pasquini, Marcelo C and Perales, Miguel-Angel and Shouval, Roni},
  title = {Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells},
  journal = {Blood},
  year = {2023},
  volume = {141},
  number = {6},
  pages = {673--677},
  doi = {10.1182/blood.2022017386}
}
Kostenlos starten →